197 related articles for article (PubMed ID: 30844485)
1. Serum protein N-glycosylation changes in multiple myeloma.
Zhang Z; Westhrin M; Bondt A; Wuhrer M; Standal T; Holst S
Biochim Biophys Acta Gen Subj; 2019 May; 1863(5):960-970. PubMed ID: 30844485
[TBL] [Abstract][Full Text] [Related]
2. N-glycosylation of serum proteins for the assessment of patients with IgD multiple myeloma.
Chen J; Fang M; Chen X; Yi C; Ji J; Cheng C; Wang M; Gu X; Sun Q; Gao C
BMC Cancer; 2017 Dec; 17(1):881. PubMed ID: 29268706
[TBL] [Abstract][Full Text] [Related]
3. Serum N-Glycans: A New Diagnostic Biomarker for Light Chain Multiple Myeloma.
Chen J; Fang M; Zhao YP; Yi CH; Ji J; Cheng C; Wang MM; Gu X; Sun QS; Chen XL; Gao CF
PLoS One; 2015; 10(6):e0127022. PubMed ID: 26075387
[TBL] [Abstract][Full Text] [Related]
4. Capillary electrophoresis analysis of N-glycosylation changes of serum paraproteins in multiple myeloma.
Kovacs Z; Simon A; Szabo Z; Nagy Z; Varoczy L; Pal I; Csanky E; Guttman A
Electrophoresis; 2017 Sep; 38(17):2115-2123. PubMed ID: 28116769
[TBL] [Abstract][Full Text] [Related]
5. Plasma N-Glycan Signatures Are Associated With Features of Inflammatory Bowel Diseases.
Clerc F; Novokmet M; Dotz V; Reiding KR; de Haan N; Kammeijer GSM; Dalebout H; Bladergroen MR; Vukovic F; Rapp E; ; Targan SR; Barron G; Manetti N; Latiano A; McGovern DPB; Annese V; Lauc G; Wuhrer M
Gastroenterology; 2018 Sep; 155(3):829-843. PubMed ID: 29792883
[TBL] [Abstract][Full Text] [Related]
6. Polyclonal Immunoglobulin G N-Glycosylation in the Pathogenesis of Plasma Cell Disorders.
Mittermayr S; Lê GN; Clarke C; Millán Martín S; Larkin AM; O'Gorman P; Bones J
J Proteome Res; 2017 Feb; 16(2):748-762. PubMed ID: 27936757
[TBL] [Abstract][Full Text] [Related]
7. Stage Dependence, Cell-Origin Independence, and Prognostic Capacity of Serum Glycan Fucosylation, β1-4 Branching, β1-6 Branching, and α2-6 Sialylation in Cancer.
Ferdosi S; Rehder DS; Maranian P; Castle EP; Ho TH; Pass HI; Cramer DW; Anderson KS; Fu L; Cole DEC; Le T; Wu X; Borges CR
J Proteome Res; 2018 Jan; 17(1):543-558. PubMed ID: 29129073
[TBL] [Abstract][Full Text] [Related]
8. Plasma N-Glycome Signature of Down Syndrome.
Borelli V; Vanhooren V; Lonardi E; Reiding KR; Capri M; Libert C; Garagnani P; Salvioli S; Franceschi C; Wuhrer M
J Proteome Res; 2015 Oct; 14(10):4232-45. PubMed ID: 26334954
[TBL] [Abstract][Full Text] [Related]
9. Murine Plasma N-Glycosylation Traits Associated with Sex and Strain.
Reiding KR; Hipgrave Ederveen AL; Rombouts Y; Wuhrer M
J Proteome Res; 2016 Oct; 15(10):3489-3499. PubMed ID: 27546880
[TBL] [Abstract][Full Text] [Related]
10. Plasma protein N-glycan signatures of type 2 diabetes.
Dotz V; Lemmers RFH; Reiding KR; Hipgrave Ederveen AL; Lieverse AG; Mulder MT; Sijbrands EJG; Wuhrer M; van Hoek M
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2613-2622. PubMed ID: 30251656
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune hepatitis displays distinctively high multi-antennary sialylation on plasma N-glycans compared to other liver diseases.
Pongracz T; Biewenga M; Stoelinga AEC; Bladergroen MR; Nicolardi S; Trouw LA; Wuhrer M; de Haan N; van Hoek B
J Transl Med; 2024 May; 22(1):456. PubMed ID: 38745252
[TBL] [Abstract][Full Text] [Related]
12. Serum N-Glycome analysis reveals pancreatic cancer disease signatures.
Vreeker GCM; Hanna-Sawires RG; Mohammed Y; Bladergroen MR; Nicolardi S; Dotz V; Nouta J; Bonsing BA; Mesker WE; van der Burgt YEM; Wuhrer M; Tollenaar RAEM
Cancer Med; 2020 Nov; 9(22):8519-8529. PubMed ID: 32898301
[TBL] [Abstract][Full Text] [Related]
13. Association of N-glycosylation with breast carcinoma and systemic features using high-resolution quantitative UPLC.
Saldova R; Asadi Shehni A; Haakensen VD; Steinfeld I; Hilliard M; Kifer I; Helland A; Yakhini Z; Børresen-Dale AL; Rudd PM
J Proteome Res; 2014 May; 13(5):2314-27. PubMed ID: 24669823
[TBL] [Abstract][Full Text] [Related]
14. Associations between plasma protein, IgG and IgA N-glycosylation and metabolic health markers in pregnancy and gestational diabetes.
Štambuk T; Kifer D; Smirčić-Duvnjak L; Vučić Lovrenčić M; Gornik O
PLoS One; 2023; 18(4):e0284838. PubMed ID: 37079606
[TBL] [Abstract][Full Text] [Related]
15. In-depth N-glycome profiling of paired colorectal cancer and non-tumorigenic tissues reveals cancer-, stage- and EGFR-specific protein N-glycosylation.
Sethi MK; Kim H; Park CK; Baker MS; Paik YK; Packer NH; Hancock WS; Fanayan S; Thaysen-Andersen M
Glycobiology; 2015 Oct; 25(10):1064-78. PubMed ID: 26085185
[TBL] [Abstract][Full Text] [Related]
16. Distinguishing Benign and Malignant Thyroid Nodules and Identifying Lymph Node Metastasis in Papillary Thyroid Cancer by Plasma
Zhang Z; Reiding KR; Wu J; Li Z; Xu X
Front Endocrinol (Lausanne); 2021; 12():692910. PubMed ID: 34248851
[TBL] [Abstract][Full Text] [Related]
17. Cystic fibrosis and bacterial colonization define the sputum N-glycosylation phenotype.
Venkatakrishnan V; Thaysen-Andersen M; Chen SC; Nevalainen H; Packer NH
Glycobiology; 2015 Jan; 25(1):88-100. PubMed ID: 25190359
[TBL] [Abstract][Full Text] [Related]
18. Sialic acid linkage-specific permethylation for improved profiling of protein glycosylation by MALDI-TOF MS.
Jiang K; Zhu H; Li L; Guo Y; Gashash E; Ma C; Sun X; Li J; Zhang L; Wang PG
Anal Chim Acta; 2017 Aug; 981():53-61. PubMed ID: 28693729
[TBL] [Abstract][Full Text] [Related]
19. Isomer-specific biomarker discovery in multiple myeloma with dual-derivatized N-glycans.
Wang C; Zhang C; Gao X; Lin JM
Anal Bioanal Chem; 2022 Jul; 414(18):5617-5626. PubMed ID: 35320367
[TBL] [Abstract][Full Text] [Related]
20. Characterization of IgG N-glycome profile in colorectal cancer progression by MALDI-TOF-MS.
Liu S; Cheng L; Fu Y; Liu BF; Liu X
J Proteomics; 2018 Jun; 181():225-237. PubMed ID: 29698801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
